Evaluation of DNA damage through cytogenetic approach in smokers and vapers with and without nicotine compared with control group
DOI:
https://doi.org/10.70099/BJ/2024.01.02.13Keywords:
cigarettes, vaping, chromosome breakage, DNA damageAbstract
The use of tobacco and electronic cigarettes is harmful to health and can cause genetic damage, increasing the risk of cancer and other serious diseases. Although e-cigarettes contain fewer toxic chemicals than conventional tobacco, recent studies have shown that the vapor caused by burning produced by e-cigarettes can also be toxic and carcinogenic. Various studies have found that those exposed to tobacco and vaping have significantly higher levels of damage to their DNA in different types of cells and tissues. Evidence has accumulated that e-cigarette vaping can alter cellular functions and DNA itself, increasing the risk of cancer and aging. The present work evaluates the cytogenetic damage in individuals exposed to conventional cigarette vapors by burning with nicotine and vapors without nicotine, compared with a non-smoking population. The study included participants with an average age of 30 years (+/-10), with a majority of men representing 70% of the sample. The Chi-square test found no significant statistical differences between the men and women exposed (p<0.05). The results of chromosomal fragility found in the four groups studied (control group, conventional smokers, vapers with nicotine and vapers without nicotine) showed breaks and gaps in one or both of the chromatids in all exposed individuals, with highly significant statistical differences (p<0.001) compared to the unexposed control group. No statistically significant differences were found between the group of conventional smokers and the vapers with and without nicotine, nor between the two types of vapers (p>0.05). In conclusion, cytogenetic evidence of DNA damage produced by vaping is shown in the same proportions as a normal cigarette. This will significantly impact public health, which must be considered in preventive actions.
References
1. Armendáriz-Castillo, I.; Guerrero, S.; Vera-Guapi, A.; Cevallos-Vilatuña, T.; García-Cárdenas, J.M.; Guevara-Ramírez, P.; López-Cortés, A.; Pérez-Villa, A.; Yumiceba, V.; Zambrano, A.K.; Leone, P.E.; Paz-y-Miño, C. Genotoxic and carcinogenic potential of compounds associated with electronic cigarettes: A systematic review. BioMed Res Int. 2019; 1386710. DOI: 10.1155/2019/1386710.
2. National Academies of Sciences, Engineering, and Medicine. Public Health Consequences of E-Cigarettes. Washington, DC: The National Academies Press. 2018. [Internet]. [Consulted Jul 2023]. Available in: https://www.nap.edu/catalog/24952/public-health-consequences-of-e-cigarettes
3. Centers for Disease Control and Prevention (CDC). Health Effects of Cigarette Smoking. 2021. [Internet]. [Consulted Jul 2023]. Available in: https://www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/effects_cig_smoking/index.htm
4. US Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. 2014. [Internet]. [Consulted Jul 2023]. Available in: https://www.ncbi.nlm.nih.gov/books/NBK179276/
5. World Health Organization (WHO). Tobacco. 2021. [Internet]. [Consulted Jul 2023]. Available in: https://www.who.int/news-room/fact-sheets/detail/tobacco
6. Tommasi, S.; Blumenfeld, H.; Besaratinia, A. Vaping Dose, Device Type, and E-Liquid Flavor are Determinants of DNA Damage in Electronic Cigarette Users. Nicotine Tob Res, 2023. [Internet]. [Consulted Jul 2023]. Available in: https://doi.org/10.1093/ntr/ntad003.
7. Environmental Health Perspectives. Metals in emissions of electronic cigarettes: results from a risk assessment. 2018. [Internet]. [Consulted Jul 2023]. Available in: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5936451/
8. Levy, D.T.; Yuan, Z.; Li, Y.; Prevalence and Characteristics of E-Cigarette Users in the United States. Int J Environ Res Public Health, 2017, 14(10):1200. DOI: 10.3390/ijerph14101200
9. Farsalinos, K.E.; Poulas, K.; Voudris, V.; Le Houezec. J. Electronic cigarette use in the European Union: analysis of a representative sample of 27 460 Europeans from 28 countries. Addiction, 2016, 111:2032–40. https://doi.org/10.1111/add.13506.
10. Lee, H.W.; Park, S.H.; Weng, M.W.; Wang, H.T.; Huang, W.C.; Lepor, H.; Tang, M.S. E-cigarette smoke damages DNA and reduces repair activity in mouse lung, heart, and bladder as well as in human lung and bladder cells. Proc Nat Acad Sci, 2018, 115(7), E1560-E1569. https://doi.org/10.1073/pnas.171818511
11. Tsai, J.C.; Saad, O.A.; Magesh, S.; Xu, J.; Lee, A.C.; Li, W.T.; Chakladar, J.; Fuster, M.M.; Chang, E.Y.; Wang-Rodriguez, J.; Ongkeko, W.M. Tobacco Smoke and Electronic Cigarette Vapor Alter Enhancer RNA Expression That Can Regulate the Pathogenesis of Lung Squamous Cell Carcinoma. Cancer (Basel). 2021, 13(16): 4225. DOI: 10.3390/cancers13164225
12. Paz-y-Miño, C.; Pérez, J.C.; Dávalos, V.; Sánchez, M.E.; Leone, P.E. Telomeric associations in cigarette smokers exposed to low levels of X-rays. Mutat Res. 2001, 490(1), 77-8016. https://doi.org/10.1016/S1383-5718(00)00156-X
13. Barrington-Trimis, J.L.; Samet, J.M.; McConnell, R. Flavorings in Electronic Cigarettes An Unrecognized Respiratory Health Hazard? JAMA, 2014, 312(23), 2493-2494. DOI: 10.1001/jama.2014.14830
14. National Cancer Institute (NCI). Smoking and Cancer. 2021. Recuperado de https://www.cancer.gov/about-cancer/causes-prevention/risk/tobacco/smoking-fact-sheet
15. US Food and Drug Administration (FDA). Vaporizers, E-Cigarettes, and other Electronic Nicotine Delivery Systems (ENDS). 2021. [Internet]. [Consulted Jul 2023]. Available in: https://www.fda.gov/tobacco-products/products-ingredients-components/vaporizers-e-cigarettes-and-other-electronic-nicotine-delivery-systems-ends
16. Alexandrof, L.B.; Ju, Y.K.; Haase, K.; Van Loo, P.; Martincorena, I.; Nik-Zainal, S.; Totoki, Y.; Fujimoto, A.; Nakagawa, H.; Shibata, T.; Campbell, P.J.; Vineis, P.; Phillips, D.H.; Stratton, M.R. Mutational signatures associated with tobacco smoking in human cancer. Science, 2016, 354(6312), 618-622. DOI: 10.1126/science.aag0299
17. Kaur, G.; Pinkston, R.; Mclemore, B.; Dorsey, W.C.; Batra, S.K.; Singh, A.P. Immunological and toxicological risk assessment of e-cigarettes. Eur Respir Rev, 2018, 27(147), 170119. DOI: 10.1183/16000617.0119-2017
18. Lee, H.W.; Park, S.H.; Weng, M.W.; Wang, H.T.; Huang, W.C.; Lepor, H.; Wu, X.R.; Chen, L.C.; Tang, M.S. E-cigarette smoke damages DNA and reduces repair activity in mouse lung, heart, and bladder as well as in human lung and bladder cells. Proc Natl Acad Sci, 2018, 115(7), E1560-E1569. DOI: 10.1073/pnas.1718185115
19. Park, J.Y.; Kim, H.J.: Kim, H.J. The effects of cigarette smoke on immune responses and the immune system in respiratory tissues. Clin Exp Otorhinolaryngol, 2018, 11(2), 69-74. DOI: 10.21053/ceo.2017.00833
20. Zhang, Y.; Sumner, W.; Chen, D.R. In vitro particle size distributions in electronic and conventional cigarette aerosols suggest comparable deposition patterns. Nicotine Tob Res, 2013, 15(2), 501-508. DOI: 10.1093/ntr/nts165
21. Zhang, Y.; Sumner, W.; Chen, D.R. In vitro exposure systems and dosimetry assessment tools for inhaled tobacco products: Workshop proceedings, conclusions and paths forward for in vitro model use. Altern Lab Anim, 2017, 45(4), 195-213. DOI: 10.1177/026119291704500305
22. Galloway, S.M.; Aardma, M.J.; Ishidate, M.; Ivett, J.L.; Kirkland, D.J.; Morita, T.; Mosesso, P.; Sofuni, T. Report from working group on in vitro test for chromosomal aberrations. Mutat Res, 1994, 312 (1994) 241–261. DOI: 10.1016/0165-1161(94)00012-3
23. Carrano, A.V.; Natarajan, A.T. Considerations for population monitoring using cytogenetic techniques, in: Proceedings of the International Commission for Protection Against Environmental Mutagens and Carcinogens, Publication no.14, Mutat Res, 1998, 204, 379–406. DOI: 10.1016/0165-1218(88)90036-5
24. Natarajan, A.T. Origin and significance of chromosomal alterations, in: G. Obe (Ed.), Mutation in Man, Springer, Berlin, Germany, 1988, pp. 156–176
25. Rubinstein, M.L.; Delucchi, K.; Benowitz, N.L.; Ramo, D.E. Adolescent exposure to toxic volatile organic chemicals from e-cigarettes. Pediatrics, 2018, 141(4), e20173557. DOI: 10.1542/peds.2017-3557
26. Platel, A.; Dusautoir, R.; Gwenola, R.; Kervoaze, G.; Dourdin, G.; Gateau, E.; Talahari, S.; Huot, L. Simar, S. Ollivier, A. Laine, W. Kluza, J. Gosset, P. Garçon, G. Anthérieu, S.; Guidice, J-M.; Nesslany, F. Comparison of the in vivo genotoxicity of electronic and conventional cigarettes aerosols after subacute, subchronic and chronic exposures. J. Hazard Mater, 2022, 5, 423. DOI: 10.1016/j.jhazmat.2021.127246
27. Moses, E.; Wang, T.; Corbett, S.; Jackson, G.R.; Drizik, E.; Perdomo, C.; Perdomo, C.; Kleerup, E.; Brooks, D.; O'Connor, G.; Dubinett, S.; Hayden, P.; Lenburg, M.E.; Spira, A. Molecular Impact of Electronic Cigarette Aerosol Exposure in Human Bronchial Epithelium. Toxicol Sci, 2017, 155(1), 248–257. DOI: 10.1093/toxsci/kfw198
28. Römer, P.; Goméz Putzer, A.; Kemmerich, R.; Mathes, B. Effects of Prenatal Electronic Cigarette Exposure On Foetal Development: a Review of the Literature. GebFra Science, Review/Übersicht, 2021, 81(11),1224-1237. DOI: 10.1055/a-1524-5155
29. CAS, "Chemical Abstracts Service". American Chemical Society, 2023, https://www.cas.org/.
30. Hoadley, K.A.; Yau, C.; Hinoue, T.; Wolf, D.M.; Lazar, A.J.; Drill, E.; Shen, R.; Taylor, A.M.; Cherniack, A.D.; Thorsson, V.; Akbani, R.; Bowlby, R.; Wong, C.K.; Wiznerowicz, M.; Sanchez-Vega, F.; Robertson, A.G.; Schneider, B.G.; Lawrence, M.S.; Noushmehrh H.; Malta, T.M. Cancer Genome Atlas Network. Stuart, J. M. Benz, C. C. Laird P, W. Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer. Cell, 2018, 173(2) 291–304,e6, https://doi,org/10,1016/j,cell,2018,03,022
Published
How to Cite
Issue
Section
Categories
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with BioNatura Journal agree to the following terms: Authors retain copyright and grant the BioNatura Institutional Publishing Consortium (BIPC) right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). This allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.